Reactive Carbonyl Species as Potential Pro-Oxidant Factors Involved in Lichen Planus Pathogenesis
Round 1
Reviewer 1 Report
Although the findings are not too surprising, the paper adds some potentially interesting aspects to the pathophysiology of lichen planus.
The TBARS-method, however, is questionable as for many aspects. Therefore, the authors should add data of another independent method for MDA and also for total antioxidant status.
The potential role of oxidized phospholipids comprising also carbonyl species has not been addressed and should be included into the discussion (e.g. Deigner/Hermetter, Current Opinion in Lipidology, June 2008, Vol. 19)
Author Response
Please see the attachment
Author Response File: Author Response.docx
Reviewer 2 Report
In this work, Mitran and co-authors measured serum levels of 4-HNE and MDA in patients affected by cutaneous lichen planus. Since 4-HNE and MDA are by-products of the majority RCGs, authors considered them as representative indicators of lipid peroxidation rate in patients. Authors reported a statistically significant increase of 4-HNE and MDA in patients with respect to controls. Moreover, they reported that 4-HNE and MDA values inversely correlate with TAS in patients.
The work is well presented and the manuscript clearly written.
Major concerns
As the authors pointed out, their findings are not completely novel in the field of cutaneous lichen planus research. Moreover, the study was conducted on a limited number of patients.
They should increase the relevance of the study.
A possibility is to report the serum levels of some component of TAS, such as folic acid or vitamin B12, as previously done by other authors for oral lichen planus patients.
In addition, authors might report about other parameters considered associated with lichen planus pathogenesis, such as iron status.
Minor concerns
Authors should report whether a correlation between TAS and 4-HNE (and/or MDA) levels exists in controls.
Methods description can be improved
Author Response
Please see the attachment.
Author Response File: Author Response.docx
Round 2
Reviewer 1 Report
the paper has improved after revision
Reviewer 2 Report
I have no additional comments